Updated Jul 16, 2026
Rose Shawn Marshall is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Shawn Marshall Rose is listed as a corporate insider connected to Nkarta, Inc. (NKTX) in an SEC filing dated January 8, 2026. Nkarta is a clinical-stage biopharmaceutical company developing allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The filing notes no stock purchases or sales by Rose for that reporting period, with the role described in the filing remarks.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-08 | NKTX | Nkarta, Inc. | A — Grant or award | 70.0K | $0.00 |
Shawn Marshall Rose is listed as a corporate insider connected to Nkarta, Inc. (NKTX) in an SEC filing dated January 8, 2026. Nkarta is a clinical-stage biopharmaceutical company developing allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The filing notes no stock purchases or sales by Rose for that reporting period, with the role described in the filing…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Rose Shawn Marshall profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.